This CME Activity has expired and is no longer available for credit.
Online Highlights from the CTCA REVIEW - Day 2: Oncology
Time to Complete
February 13, 2013
August 12, 2013
1.50 / AMA PRA Category 1 Credit(s)TM 1.50 / CE for Nurses
Jointly sponsored by Dannemiller Inc. and Athena Education Group, LLC
These activities are supported by an educational grant from Cancer Treatment Centers of America.
Keeping up with new data and applying up-to-date information in treating patients with cancer has been identified by healthcare professionals as the biggest challenge in the treatment of hematologic and oncologic disorders. Featuring a faculty of internationally recognized experts, the CTCA REVIEW online webcasts highlight cutting-edge research and clinical studies presented during recent American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO) annual meetings. As highlights from the annual CTCA REVIEW, a live review course hosted by the Cancer Treatment Centers of America, the course material has been divided into two online activities. This online activity highlights Oncology/Solid Tumor content. A second online activity highlights Hematology/Oncology content.
The CTCA REVIEW Online Webcasts are intended for healthcare providers involved in the care of hematology and oncology patients, including medical oncologists, hematologists, radiation oncologists, radiologists, pathologists, oncology fellows, resident trainees, primary care providers, nurse practitioners, physician assistants, nurses, chiropractors, naturopathic physicians, and pharmacists.
After participating in each CTCA REVIEW Online Webcast, learners should be able to:
Interpret new and emerging data presented at the ASH and ASCO annual conferences
Incorporate newer evidence- based data to assess the care of their patients with cancer
Incorporate knowledge gained into appropriate management strategies to improve outcomes in patients with cancer
Utilize current standards of care for patients with cancer
Head and Neck Cancer Ezra E.W. Cohen, MD Associate Professor Department of Medicine University of Chicago Medical School Co-Director, Head and Neck Cancer Program University of Chicago Comprehensive Cancer Center Chicago, IL
Ezra E.W. Cohen, MD, has reported that he was a consultant/advisory board member for Biocon and Vascular Biogenics.
Breast Cancer Julie R. Gralow, MD Professor and Director of Breast Medical Oncology University of Washington School of Medicine and Seattle Cancer Care Alliance Member, Fred Hutchinson Cancer Research Center Seattle, WA
Julie R. Gralow, MD, has reported that she was an investigator for Amgen, Genentech, Novartis, and Roche.
Breast Cancer: Updates in Radiation Oncology Dean Conterato, MD Radiation Oncologist Cancer Treatment Centers of America Zion, IL
Dean Conterato, MD, has reported no conflicts of interest.
Skin Cancers Antoni Ribas, MD Professor of Medicine, Professor of Surgery, Professor of Molecular and Medical Pharmacology Director, Tumor Immunology Program Jonsson Comprehensive Cancer Center David Geffen School of Medicine, University of California Los Angeles (UCLA) Los Angeles, CA
Antoni Ribas, MD, has reported that he was a consultant/advisory board member for Amgen, Celgene, GlaxoSmithKline, and Millenium Pharmaceuticals, and was an investigator for Bristol-Myers Squibb, Genentech, GlaxoSmithKline, and Millenium Pharmaceuticals.
Gastrointestinal Cancers David H. Ilson, MD, PhD Attending Physician Memorial Hospital for Cancer and Allied Diseases Department of Medicine, Gastrointestinal Service Member, Memorial Sloan Kettering Cancer Center Professor of Medicine, Weill Medical College of Cornell University NY Presbyterian, New York, NY
David H. Ilson, MD, PhD, has reported that he was an investigator for Bayer and Roche.
Gynecologic Cancer Maurie Markman, MD Senior Vice President of Clinical Affairs National Director of Medical Oncology Cancer Treatment Centers of America Philadelphia, PA
Maurie Markman, MD, has reported that he was a consultant/advisory board member for Genentech.
Neuro-Oncology Jan C. Buckner Professor of Oncology Mayo Clinic Rochester, MN
Jan C. Buckner, MD, has reported that he was a speaker and consultant/advisory board member for EMD Serono.
Lung Cancer Ramaswamy Govindan, MD Professor of Medicine Division of Medical Oncology Washington University School of Medicine Saint Louis, MO
Ramaswamy Govindan, MD, has reported that he was a consultant/advisory board member for AstraZeneca, Boehringer-Ingelheim, Bristol-Myers Squibb, Covidien, Genentech, GlaxoSmithKline, and Pfizer.
Genitourinary Cancer- Novel Management Strategies and Updates Ronald M. Bukowski, MD Emeritus Staff Physician Cleveland Clinic Taussig Cancer Center Cleveland Clinic Foundation Cleveland, OH
Ronald M. Bukowski, MD, has reported that he was a speaker for GlaxoSmithKline, Novartis, and Pfizer, and was a consultant/advisory board member for Argos Therapeutics, AstraZeneca, Bristol-Myers Squibb, Genentech, GlaxoSmithKline, Novartis, Pfizer, and Vicus Therapeutics.
GIST & Soft Tissue Sarcoma Richard F. Riedel, MD Assistant Professor, Division of Medical Oncology Duke University Medical Center Associate Director, Duke Sarcoma Program Duke Cancer Institute Durham, NC
Richard F. Riedel, MD, has reported that he was a speaker for Novartis and Pfizer, was a consultant/advisory board member for INC Research and Merck, and was an investigator for Astex Pharmaceuticals, Eisai, GlaxoSmithKline, INC Research, Infinity Oncology, Merck Novartis, and Threshold Pharmaceuticals.
Genetic Testing in Familial Cancer Syndromes James Ford, MD Associate Professor of Medicine and Genetics Division of Oncology Director, Program for Clinical Cancer Genetics Stanford University School of Medicine Stanford, CA
James Ford, MD, has reported no c
Planning Committee Disclosures
Dannemiller, Inc. Bernard Abrams, MD, content reviewer and Dannemiller Medical Director, has reported no conflicts of interest.
Michelle Montgomery, Dannemiller Director of Continuing Education, has reported no conflicts of interest.
Athena Education Group, LLC Nike Gazonas, MS, has reported no conflicts of interest.
Shiva Noorchashm, has reported no conflicts of interest.
AMA PRA Category 1 Credit(s)TM
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Dannemiller and Athena Education Group. Dannemiller is accredited by the ACCME to provide continuing medical education for physicians.
Dannemiller designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Dannemiller is a provider approved by the California Board of Registered Nursing, Provider Number 4229 for 1.5 contact hours. RNs outside California must verify with their licensing agency for approval of this course.
To resolve identified/potential conflicts of interest, the educational content was fully reviewed by a physician member of the Dannemiller Clinical Content Review Committee who have no financial relationships with commercial interests. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The faculty have been asked to disclose this information when presented. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, learners should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program.
The CTCA REVIEW is not an official program of ASH or ASCO, nor is it endorsed by ASH or ASCO. The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller, Athena Education Group, or CTCA. This material is prepared based upon a review of multiple sources of information, but it is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter before relying solely upon the information contained within this educational activity.
Method of Participation To receive continuing education credit, participants should review all program materials in their entirety, complete and submit the online post-test and evaluation, and score at least 70% on the post-test. A statement of credit will be available for printing upon successful completion.
If you have any questions relating to the accreditation for this activity, please contact email@example.com.